Pro Dex (PDEX) Cash from Operations Growth (3y) (2013 - 2026)
Pro Dex (PDEX) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -10.46% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 16.21% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 24.18% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -14.72% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 13.75% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -5.42% |
| 10 | Pro Dex | 209.47 Mn | 198.49 Mn | 6.13 Mn | -11.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.27% |
| Dec 31, 2025 | 122.69% |
| Sep 30, 2025 | -7.22% |
| Jun 30, 2025 | 68.00% |
| Mar 31, 2025 | 52.40% |
| Dec 31, 2024 | -67.91% |
| Sep 30, 2024 | -11.27% |
| Jun 30, 2024 | 12.96% |
| Mar 31, 2024 | 45.00% |
| Dec 31, 2023 | -28.87% |
| Sep 30, 2023 | 34.65% |
| Jun 30, 2023 | -40.82% |
| Mar 31, 2017 | 57.48% |
| Dec 31, 2016 | 34.52% |
| Sep 30, 2016 | 35.69% |
| Mar 31, 2016 | -8.15% |
| Dec 31, 2015 | 35.82% |
| Sep 30, 2015 | -55.04% |
| Mar 31, 2015 | -39.22% |
| Dec 31, 2014 | 39.95% |